Insider · CIK 0001955244

Berman David M

Reports to the SEC for 1 company · ABINGDON, OXFORDSHIRE, X0

sec.gov

Transactions

Companies

Filings

CIK

0001955244

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-18	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−5,965 sh	$32.35	−$193K	5,859
2026-02-17	IMCRImmunocore Holdings plcM Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	+11.8K sh	—	—	11,824
2026-02-17	IMCRImmunocore Holdings plc · Restricted Share UnitsM Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	−11.8K sh	—	—	35,473
2025-12-05	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−572 sh	$40.14	−$23K	0
2025-12-05	IMCRImmunocore Holdings plc · Employee Share Option (Right to Buy)M Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	−572 sh	—	—	11,832
2025-12-05	IMCRImmunocore Holdings plcM Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	+572 sh	$17.46	+$9,987.12	572
2025-12-04	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−31.3K sh	$40.26	−$1.26M	0
2025-12-04	IMCRImmunocore Holdings plcM Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	+31.3K sh	$17.46	+$547K	31,341
2025-12-04	IMCRImmunocore Holdings plc · Employee Share Option (Right to Buy)M Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	−31.3K sh	—	—	12,404
2025-11-28	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−5,521 sh	$40.09	−$221K	0
2025-11-28	IMCRImmunocore Holdings plcM Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	+5,521 sh	$17.46	+$96.4K	5,521
2025-11-28	IMCRImmunocore Holdings plc · Employee Share Option (Right to Buy)M Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	−5,521 sh	—	—	43,745
2025-11-26	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−69.4K sh	$40.12	−$2.78M	0
2025-11-26	IMCRImmunocore Holdings plc · Employee Share Option (Right to Buy)M Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	−69.4K sh	—	—	49,266
2025-11-26	IMCRImmunocore Holdings plcM Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	+69.4K sh	$17.46	+$1.21M	69,404
2025-11-25	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−18K sh	$40.03	−$721K	0
2025-11-25	IMCRImmunocore Holdings plc · Employee Share Option (Right to Buy)M Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	−18K sh	—	—	118,670
2025-11-25	IMCRImmunocore Holdings plcM Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	+18K sh	$17.46	+$315K	18,020
2025-11-24	IMCRImmunocore Holdings plcM Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	+100 sh	$17.46	+$1,746	100
2025-11-24	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−100 sh	$40.00	−$4,000	0
2025-11-24	IMCRImmunocore Holdings plc · Employee Share Option (Right to Buy)M Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	−100 sh	—	—	136,690
2025-09-30	IMCRImmunocore Holdings plcM Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	+61.8K sh	$17.46	+$1.08M	61,849
2025-09-30	IMCRImmunocore Holdings plc · Employee Share Option (Right to Buy)M Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	−61.8K sh	—	—	136,790
2025-09-30	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−61.8K sh	$35.23	−$2.18M	0
2025-09-15	IMCRImmunocore Holdings plcM Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	+200 sh	$17.46	+$3,492	200
2025-09-15	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−200 sh	$35.01	−$7,002	0
2025-09-15	IMCRImmunocore Holdings plc · Employee Share Option (Right to Buy)M Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	−200 sh	—	—	198,639
2025-09-12	IMCRImmunocore Holdings plc · Employee Share Option (Right to Buy)M Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	−22.5K sh	—	—	198,839
2025-09-12	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−1,300 sh	$36.31	−$47.2K	0
2025-09-12	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−21.2K sh	$35.63	−$756K	1,300
2025-09-12	IMCRImmunocore Holdings plcM Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	+22.5K sh	$17.46	+$393K	22,532
2025-09-11	IMCRImmunocore Holdings plcM Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	+19.1K sh	$17.46	+$333K	19,081
2025-09-11	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−19.1K sh	$36.28	−$692K	0
2025-09-11	IMCRImmunocore Holdings plc · Employee Share Option (Right to Buy)M Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	−19.1K sh	—	—	221,371
2025-09-10	IMCRImmunocore Holdings plcM Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	+31.3K sh	$17.46	+$547K	31,338
2025-09-10	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−30.1K sh	$36.12	−$1.09M	1,200
2025-09-10	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−1,200 sh	$36.77	−$44.1K	0
2025-09-10	IMCRImmunocore Holdings plc · Employee Share Option (Right to Buy)M Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	−31.3K sh	—	—	240,452
2025-02-17	IMCRImmunocore Holdings plc · Employee Share Option (Right to Buy)A Award	HEAD OF R&D	AAward	+130K sh	—	—	129,518
2025-02-17	IMCRImmunocore Holdings plc · Restricted Share UnitsA Award	HEAD OF R&D	AAward	+47.3K sh	—	—	47,297
2024-02-28	IMCRImmunocore Holdings plc · Employee Share Option (Right to Buy)M Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	−36.5K sh	—	—	271,790
2024-02-28	IMCRImmunocore Holdings plcM Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	+36.5K sh	$17.46	+$637K	36,509
2024-02-28	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−16.9K sh	$67.61	−$1.14M	19,609
2024-02-28	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−7,472 sh	$68.84	−$514K	12,137
2024-02-28	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−10.9K sh	$69.73	−$763K	1,200
2024-02-28	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−1,200 sh	$70.45	−$84.5K	0
2024-02-27	IMCRImmunocore Holdings plc · Employee Share Option (Right to Buy)M Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	−54.9K sh	—	—	308,299
2024-02-27	IMCRImmunocore Holdings plcM Exercise/Conversion	HEAD OF R&D	MExercise/Conversion	+54.9K sh	$17.46	+$959K	54,938
2024-02-27	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−3,394 sh	$71.97	−$244K	0
2024-02-27	IMCRImmunocore Holdings plcS Sale	HEAD OF R&D	SSale	−25.9K sh	$71.32	−$1.85M	3,394

Recent filings

Accepted (ET)
Feb 194
Berman David M0001955244-26-000002
SEC(opens sec.gov)
Dec 84
Berman David M0001955244-25-000015
SEC(opens sec.gov)
Dec 14
Berman David M0001955244-25-000013
SEC(opens sec.gov)
Nov 264
Berman David M0001955244-25-000011
SEC(opens sec.gov)

Companies

Immunocore Holdings plcHEAD OF R&DIMCR

Address

C/O IMMUNOCORE HOLDINGS PLC 92 PARK DRIVE, MILTON PARK

ABINGDON, OXFORDSHIRE, X0, OX14 4RY